register free | resend password

Novus Teams Up With PR Revolution to Execute Go-to-Market Strategy

ID: 1325831
recent pressrelease next pressrelease

(businesspress24) - MIAMI, FL -- (Marketwired) -- 12/17/14 -- Novus Acquisition & Development Corp (OTC PINK: NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, "Novus MedPlan," is proud to announce that it has retained PR Revolution () as its public relations and marketing agency of record. The agency will be responsible for managing print and local media relations as well as marketing and branding direction for the Novus MedPlan as Novus continues to expand throughout the country.

"We are very pleased to have the support of PR Revolution as we continue to expand our provider footprint," stated Frank Labrozzi, Chairman of Novus. "With extensive public relations, marketing experience and substantial success for their clients in the cannabis and insurance industries, PR Revolution is the ideal partner to help generate excitement about Novus MedPlan and our providers."

Novus MedPlan is a discount program designed to save medical marijuana patients money on their medicinals as well as save all consumers money on holistic and alternative medicines. Members receive access to an exclusive provider network that Novus is building throughout the country. The network is being strategically developed to provide easy access to providers no matter where network members are located throughout the states in which the Novus MedPlan is available.

"Novus MedPlan is a great concept and its timing is perfect with the rapid expansion of the cannabis industry. It also fits perfectly within our cannabis client portfolio of clients, which is a sector our agency has been able to have tremendous success in over the past few years with feature stories on CNBC and FOX Business, as well as in numerous print publications such as Forbes, Time Magazine, US Today, Fast Company and Huffington Post," says Elyse Segall, CEO of PR Revolution.

Novus Acquisition & Development Corp. ("Novus") provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians'' education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government''s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm''s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visit for more information.

This release includes forward-looking statements, which are based on certain assumptions and reflects management''s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For Investor Relations contact:

Main Tel: (855) 422-4463

Novus Acquisition & Development Corp
Gary F. Labrozzi
Website: or

Keywords (optional):

novus-acquisition-undamp, development-corp,

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: Marketwired
print pressrelease  send to a friend  

Date: 12/17/2014 - 13:00
Language: English
News-ID 1325831
Character count: 0
Firma: Novus Acquisition & Development Corp
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: MIAMI, FL


Number of hits: 60


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 76

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.